Prenatal maternal antidepressants, anxiety, and depression and offspring DNA methylation: epigenome-wide associations at birth and persistence into early childhood

Abstract Background Maternal mood disorders and their treatment during pregnancy may have effects on the offspring epigenome. We aim to evaluate associations of maternal prenatal antidepressant use, anxiety, and depression with cord blood DNA methylation across the genome at birth and test for persi...

Full description

Bibliographic Details
Main Authors: Andres Cardenas, Sabrina Faleschini, Andrea Cortes Hidalgo, Sheryl L. Rifas-Shiman, Andrea A. Baccarelli, Dawn L. DeMeo, Augusto A. Litonjua, Alexander Neumann, Janine F. Felix, Vincent W. V. Jaddoe, Hanan El Marroun, Henning Tiemeier, Emily Oken, Marie-France Hivert, Heather H. Burris
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Clinical Epigenetics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13148-019-0653-x
_version_ 1818358804976238592
author Andres Cardenas
Sabrina Faleschini
Andrea Cortes Hidalgo
Sheryl L. Rifas-Shiman
Andrea A. Baccarelli
Dawn L. DeMeo
Augusto A. Litonjua
Alexander Neumann
Janine F. Felix
Vincent W. V. Jaddoe
Hanan El Marroun
Henning Tiemeier
Emily Oken
Marie-France Hivert
Heather H. Burris
author_facet Andres Cardenas
Sabrina Faleschini
Andrea Cortes Hidalgo
Sheryl L. Rifas-Shiman
Andrea A. Baccarelli
Dawn L. DeMeo
Augusto A. Litonjua
Alexander Neumann
Janine F. Felix
Vincent W. V. Jaddoe
Hanan El Marroun
Henning Tiemeier
Emily Oken
Marie-France Hivert
Heather H. Burris
author_sort Andres Cardenas
collection DOAJ
description Abstract Background Maternal mood disorders and their treatment during pregnancy may have effects on the offspring epigenome. We aim to evaluate associations of maternal prenatal antidepressant use, anxiety, and depression with cord blood DNA methylation across the genome at birth and test for persistence of associations in early and mid-childhood blood DNA. Methods A discovery phase was conducted in Project Viva, a prospective pre-birth cohort study with external replication in an independent cohort, the Generation R Study. In Project Viva, pregnant women were recruited between 1999 and 2002 in Eastern Massachusetts, USA. In the Generation R Study, pregnant women were recruited between 2002 and 2006 in Rotterdam, the Netherlands. In Project Viva, 479 infants had data on maternal antidepressant use, anxiety, depression, and cord blood DNA methylation, 120 children had DNA methylation measured in early childhood (~ 3 years), and 460 in mid-childhood (~ 7 years). In the Generation R Study, 999 infants had data on maternal antidepressants and cord blood DNA methylation. The prenatal antidepressant prescription was obtained from medical records. At-mid pregnancy, symptoms of anxiety and depression were assessed with the Pregnancy-Related Anxiety Scale and the Edinburgh Postnatal Depression Scale in Project Viva and with the Brief Symptom Inventory in the Generation R Study. Genome-wide DNA methylation was measured using the Infinium HumanMethylation450 BeadChip in both cohorts. Results In Project Viva, 2.9% (14/479) pregnant women were prescribed antidepressants, 9.0% (40/445) experienced high pregnancy-related anxiety, and 8.2% (33/402) reported symptoms consistent with depression. Newborns exposed to antidepressants in pregnancy had 7.2% lower DNA methylation (95% CI, − 10.4, − 4.1; P = 1.03 × 10−8) at cg22159528 located in the gene body of ZNF575, and this association replicated in the Generation R Study (β = − 2.5%; 95% CI − 4.2, − 0.7; P = 0.006). In Project Viva, the association persisted in early (β = − 6.2%; 95% CI − 10.7, − 1.6) but not mid-childhood. We observed cohort-specific associations for maternal anxiety and depression in Project Viva that did not replicate. Conclusions The ZNF575 gene is involved in transcriptional regulation but specific functions are largely unknown. Given the widespread use of antidepressants in pregnancy, as well as the effects of exposure to anxiety and depression, implications of potential fetal epigenetic programming by these risk factors and their impacts on development merit further investigation.
first_indexed 2024-12-13T20:34:50Z
format Article
id doaj.art-682775dc21e84942ba8be26166a4952c
institution Directory Open Access Journal
issn 1868-7075
1868-7083
language English
last_indexed 2024-12-13T20:34:50Z
publishDate 2019-03-01
publisher BMC
record_format Article
series Clinical Epigenetics
spelling doaj.art-682775dc21e84942ba8be26166a4952c2022-12-21T23:32:18ZengBMCClinical Epigenetics1868-70751868-70832019-03-0111111110.1186/s13148-019-0653-xPrenatal maternal antidepressants, anxiety, and depression and offspring DNA methylation: epigenome-wide associations at birth and persistence into early childhoodAndres Cardenas0Sabrina Faleschini1Andrea Cortes Hidalgo2Sheryl L. Rifas-Shiman3Andrea A. Baccarelli4Dawn L. DeMeo5Augusto A. Litonjua6Alexander Neumann7Janine F. Felix8Vincent W. V. Jaddoe9Hanan El Marroun10Henning Tiemeier11Emily Oken12Marie-France Hivert13Heather H. Burris14Division of Environmental Health Sciences, School of Public Health, University of California, BerkeleySchool of Psychology, Laval UniversityDepartment of Child and Adolescent Psychiatry and Psychology, Erasmus MC – Sophia Children’s HospitalDivision of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care InstituteDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia UniversityChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDivision of Pediatric Pulmonary Medicine, University of Rochester Medical CenterDepartment of Child and Adolescent Psychiatry and Psychology, Erasmus MC – Sophia Children’s HospitalGeneration R Study Group, Erasmus MC, University Medical Center RotterdamGeneration R Study Group, Erasmus MC, University Medical Center RotterdamDepartment of Child and Adolescent Psychiatry and Psychology, Erasmus MC – Sophia Children’s HospitalDepartment of Child and Adolescent Psychiatry and Psychology, Erasmus MC – Sophia Children’s HospitalDivision of Environmental Health Sciences, School of Public Health, University of California, BerkeleyDivision of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care InstituteDivision of Neonatology, Department of Pediatrics, Children’s Hospital of Philadelphia and Perelman School of Medicine, University of PennsylvaniaAbstract Background Maternal mood disorders and their treatment during pregnancy may have effects on the offspring epigenome. We aim to evaluate associations of maternal prenatal antidepressant use, anxiety, and depression with cord blood DNA methylation across the genome at birth and test for persistence of associations in early and mid-childhood blood DNA. Methods A discovery phase was conducted in Project Viva, a prospective pre-birth cohort study with external replication in an independent cohort, the Generation R Study. In Project Viva, pregnant women were recruited between 1999 and 2002 in Eastern Massachusetts, USA. In the Generation R Study, pregnant women were recruited between 2002 and 2006 in Rotterdam, the Netherlands. In Project Viva, 479 infants had data on maternal antidepressant use, anxiety, depression, and cord blood DNA methylation, 120 children had DNA methylation measured in early childhood (~ 3 years), and 460 in mid-childhood (~ 7 years). In the Generation R Study, 999 infants had data on maternal antidepressants and cord blood DNA methylation. The prenatal antidepressant prescription was obtained from medical records. At-mid pregnancy, symptoms of anxiety and depression were assessed with the Pregnancy-Related Anxiety Scale and the Edinburgh Postnatal Depression Scale in Project Viva and with the Brief Symptom Inventory in the Generation R Study. Genome-wide DNA methylation was measured using the Infinium HumanMethylation450 BeadChip in both cohorts. Results In Project Viva, 2.9% (14/479) pregnant women were prescribed antidepressants, 9.0% (40/445) experienced high pregnancy-related anxiety, and 8.2% (33/402) reported symptoms consistent with depression. Newborns exposed to antidepressants in pregnancy had 7.2% lower DNA methylation (95% CI, − 10.4, − 4.1; P = 1.03 × 10−8) at cg22159528 located in the gene body of ZNF575, and this association replicated in the Generation R Study (β = − 2.5%; 95% CI − 4.2, − 0.7; P = 0.006). In Project Viva, the association persisted in early (β = − 6.2%; 95% CI − 10.7, − 1.6) but not mid-childhood. We observed cohort-specific associations for maternal anxiety and depression in Project Viva that did not replicate. Conclusions The ZNF575 gene is involved in transcriptional regulation but specific functions are largely unknown. Given the widespread use of antidepressants in pregnancy, as well as the effects of exposure to anxiety and depression, implications of potential fetal epigenetic programming by these risk factors and their impacts on development merit further investigation.http://link.springer.com/article/10.1186/s13148-019-0653-xMaternal depressionMaternal anxietyAntidepressantsDNA methylationFetal programming
spellingShingle Andres Cardenas
Sabrina Faleschini
Andrea Cortes Hidalgo
Sheryl L. Rifas-Shiman
Andrea A. Baccarelli
Dawn L. DeMeo
Augusto A. Litonjua
Alexander Neumann
Janine F. Felix
Vincent W. V. Jaddoe
Hanan El Marroun
Henning Tiemeier
Emily Oken
Marie-France Hivert
Heather H. Burris
Prenatal maternal antidepressants, anxiety, and depression and offspring DNA methylation: epigenome-wide associations at birth and persistence into early childhood
Clinical Epigenetics
Maternal depression
Maternal anxiety
Antidepressants
DNA methylation
Fetal programming
title Prenatal maternal antidepressants, anxiety, and depression and offspring DNA methylation: epigenome-wide associations at birth and persistence into early childhood
title_full Prenatal maternal antidepressants, anxiety, and depression and offspring DNA methylation: epigenome-wide associations at birth and persistence into early childhood
title_fullStr Prenatal maternal antidepressants, anxiety, and depression and offspring DNA methylation: epigenome-wide associations at birth and persistence into early childhood
title_full_unstemmed Prenatal maternal antidepressants, anxiety, and depression and offspring DNA methylation: epigenome-wide associations at birth and persistence into early childhood
title_short Prenatal maternal antidepressants, anxiety, and depression and offspring DNA methylation: epigenome-wide associations at birth and persistence into early childhood
title_sort prenatal maternal antidepressants anxiety and depression and offspring dna methylation epigenome wide associations at birth and persistence into early childhood
topic Maternal depression
Maternal anxiety
Antidepressants
DNA methylation
Fetal programming
url http://link.springer.com/article/10.1186/s13148-019-0653-x
work_keys_str_mv AT andrescardenas prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT sabrinafaleschini prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT andreacorteshidalgo prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT sheryllrifasshiman prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT andreaabaccarelli prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT dawnldemeo prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT augustoalitonjua prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT alexanderneumann prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT janineffelix prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT vincentwvjaddoe prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT hananelmarroun prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT henningtiemeier prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT emilyoken prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT mariefrancehivert prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood
AT heatherhburris prenatalmaternalantidepressantsanxietyanddepressionandoffspringdnamethylationepigenomewideassociationsatbirthandpersistenceintoearlychildhood